We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Chip-in-a-Tube Technology to Simplify Digital PCR Procedures

By LabMedica International staff writers
Posted on 11 Nov 2014
An advanced chip-in-a-tube, digital PCR system will soon be available for use by biotech and other life science laboratories involved in nucleic acid research.

JN Medsys (Singapore) introduced the Clarity digital PCR system at the American Society for Human Genetics exhibition that was held October 19–21, 2014, in San Diego (CA, USA).

The system features tube strips based on an innovative chip-in-a-tube design and a dedicated tube strip reader. More...
The tube strip format simplifies the cumbersome workflow typically associated with digital PCR by making it quick and easy to load, partition, thermal cycle, and detect reaction products. The unique chip-in-a-tube design combines the robustness of chip-based partitioning with the ease-of-use of a tube strip. Each PCR mix is rapidly subdivided into 10,000 partitions by a high-density chip within each tube. The high-density chip allows a large number of partitions to exist within the small confines of a PCR tube. Partitioning can be completed within one minute and is done in-tube without additional equipment or multiple pipetting steps. Up to eight reactions can be run in parallel to yield 80,000 partitions per tube strip. Clarity tube strips are compatible with conventional thermal cyclers to allow up to 96 digital PCR reactions per run.

Designed to work with the tube strips, the Clarity Reader detects fluorescent signals from every single partition of the digital PCR reactions with high sensitivity. Unlike droplet-based systems, partitions in each tube are detected concurrently, saving time and allowing tube strips to be read in just minutes. Closed tube format prevents cross contamination among reactions. Walk away operation allows multiple reactions to be read automatically with no user intervention, providing an easy workflow for high throughput digital PCR experiments.

Dr. Johnson Ng, CEO of JN Medsys, said, “Right from the start, we wanted to develop a product that would transform the way digital PCR was carried out. Our aim is to remove all barriers to digital PCR so that more scientists can have access to this powerful technology, and harness it to develop better tests for diseases like cancer or infectious diseases, and to improve the lives of people. We want our Clarity digital PCR system to be the platform technology that enables that. Our purpose at JN Medsys is to make lives better through providing superior products and outstanding service to our community.”

Related Links:

JN Medsys



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.